Congenital Heart Disease
M-A | Thromboprophylaxis in patients with Fontan circulation
2 Mar, 2023 | 12:57h | UTCThromboprophylaxis in Patients With Fontan Circulation – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: Thromboprophylaxis in Patients With Fontan Circulation – American College of Cardiology
Commentary from the author on Twitter (thread – click for more)
🔥Hot off the press🔥Read our new paper about #Thromboprophylaxis in patients with #Fontan #circulation just published in @JACCJournals@ACCinTouch.
Article link: https://t.co/eeu6kT7PDH— Jef Van den Eynde (@JefVandenEynde) January 23, 2023
Retrospective Cohort | Lifetime risk of comorbidity in patients with simple congenital heart disease
17 Feb, 2023 | 12:57h | UTC
Commentary on Twitter
Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study https://t.co/r8WDeL5Ra5 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/llrApfl2xR
— European Society of Cardiology Journals (@ESC_Journals) December 14, 2022
SR | Paracetamol for patent ductus arteriosus in preterm or low birth weight infants
3 Feb, 2023 | 13:47h | UTC
Commentary on Twitter
Is paracetamol effective and safe, compared with placebo, no intervention, or another prostaglandin inhibitor, for PDA in preterm or LBWls? Jasani B, @souvik_neo, and Shah PS updated a systematic review in @CochraneLibrary.https://t.co/ZD3tMC6LuH#EBNeoAlerts #NeoEBM pic.twitter.com/gmQc1eem4n
— Evidence-Based Neo (@EBNEO) December 29, 2022
Cohort Study | Lifetime burden of morbidity in patients with isolated congenital ventricular septal defect
1 Feb, 2023 | 13:02h | UTC
AHA Statement | Perioperative care for children with congenital heart disease presenting for noncardiac procedures
26 Jan, 2023 | 12:26h | UTCCommentary: AHA Weighs in on Risks of Noncardiac Surgery in Congenital HD Patients – TCTMD
AHA Scientific Statement | Palliative care across the life span for children with heart disease
15 Jan, 2023 | 20:19h | UTCTop Things to Know: Palliative Care Across Lifespan for Children With Heart Disease – American Heart Association
Commentary: Palliative Care Across the Lifespan for Children with Heart Disease – American Heart Association
Cohort Study | Procedural characteristics and outcomes of transcatheter interventions for aortic coarctation
13 Jan, 2023 | 13:16h | UTC
Commentary on Twitter
Practice patterns and acute outcomes of #transcatheter #coarctation interventions in the @ACCinTouch #NCDR IMPACT Registry ➡️ https://t.co/tkFJ3tiSvu@DrAdaStefanescu @AmiBhattMD @erichorlick pic.twitter.com/lzVr6KV0mE
— MyJSCAI (@MyJSCAI) September 27, 2022
Consensus Document | Management of infants and neonates with tetralogy of Fallot
11 Jan, 2023 | 14:21h | UTC
Commentary on Twitter
AATS announces the publication of “The Management of Infants and Neonates with Tetralogy of Fallot" in #JTCVS! Read the AATS 2022 Expert Consensus Document here: https://t.co/gyWgSkZ6BB @EHStephensCHD @abgoldstoneMD @LCKaneMD @RickOhyeMD @Dr_dUdekem @tssmn #CHD #tetralogyofFallot pic.twitter.com/5nam4bpfbN
— AATS Journals (@AATSJournals) October 27, 2022
Cohort Study | Risk of heart failure in congenital heart disease
10 Jan, 2023 | 14:14h | UTCNews Release: Heart failure more common in heart defect survivors starting at young age – American Heart Association
SR | BNP and NT-proBNP for the diagnosis of hemodynamically significant patent ductus arteriosus in preterm neonates.
14 Dec, 2022 | 14:49h | UTC
Cohort Study | Survival of patients with congenital ventricular septal defect.
13 Dec, 2022 | 14:21h | UTCSurvival of patients with congenital ventricular septal defect – European Heart Journal
Commentary: Survival of Patients With Congenital Ventricular Septal Defect – American College of Cardiology
Commentary on Twitter
Survival of patients with congenital ventricular septal defect https://t.co/Qr8dLv4w2h @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/aWeFfbFP4V
— European Society of Cardiology Journals (@ESC_Journals) November 29, 2022
RCT | Expectant management or early ibuprofen for patent ductus arteriosus.
9 Dec, 2022 | 13:38h | UTCExpectant Management or Early Ibuprofen for Patent Ductus Arteriosus – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In this trial involving preterm infants with patent ductus arteriosus, expectant management was noninferior to ibuprofen therapy for the primary outcome of necrotizing enterocolitis, bronchopulmonary dysplasia, or death at 36 weeks. https://t.co/vzrpruce9F pic.twitter.com/fW09Sz8O8o
— NEJM (@NEJM) December 6, 2022
Preliminary study suggests that Edoxaban is a safe alternative for preventing thromboembolism in pediatric patients with cardiac disease.
9 Dec, 2022 | 13:07h | UTCEdoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease – Journal of the American College of Cardiology (link to abstract – $ for full-text)
AHA Scientific Statement | Arrhythmias in repaired Tetralogy of Fallot.
9 Nov, 2022 | 12:33h | UTCSummary: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Top Things to Know: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Commentary: Challenges in Managing Arrhythmias in Adult Tetralogy of Fallot – American Heart Association
RCT | In infants undergoing heart surgery, prophylactic methylprednisolone did not significantly improve outcomes.
9 Nov, 2022 | 12:31h | UTCMethylprednisolone for Heart Surgery in Infants — A Randomized, Controlled Trial – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Steroids during surgery may not be helpful for infants having heart bypass – American Heart Association
Commentary on Twitter
In this randomized, controlled trial involving infants undergoing surgery with cardiopulmonary bypass, prophylactic use of methylprednisolone did not significantly reduce the likelihood of a worse outcome. #AHA22 https://t.co/jaza6JCAuk pic.twitter.com/lLrxci7SaE
— NEJM (@NEJM) November 6, 2022
Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider.
7 Sep, 2022 | 12:34h | UTC
JCS 2022 Guideline on management and re-interventional therapy in patients with congenital heart disease in the long-term after the initial repair.
2 Sep, 2022 | 13:10h | UTC
M-A | The outcome of post-cardiotomy extracorporeal membrane oxygenation in neonates and pediatric patients.
4 Aug, 2022 | 13:48h | UTC
Registry-based cohort study | Interventions in adults with repaired coarctation of the aorta.
7 Jul, 2022 | 12:29h | UTC
M-A: Patent ductus arteriosus stent vs. surgical aortopulmonary shunt for initial palliation of cyanotic congenital heart disease with ductal‐dependent pulmonary blood flow.
30 Jun, 2022 | 11:00h | UTC
Guidelines for the use of cardiac magnetic resonance in pediatric congenital and acquired heart disease.
22 Jun, 2022 | 11:31h | UTC